Levoleucovorin
Small Molecule
Overview
Levoleucovorin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1908841).
Patent & exclusivity (US)
Per the FDA Orange Book (7 approved US products), the latest listed US patent on Levoleucovorin expires 25 Mar 2039. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- (2S)-2-[[4-[[(6S)-2-amino-5-formyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl]methylamino]benzoyl]amino]pentanedioic acid
- Canonical SMILES
- C1[C@@H](N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O
- InChIKey
- VVIAGPKUTFNRDU-STQMWFEESA-N
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.